CN104398884A - Traditional Chinese medicine composition for treating emphysema - Google Patents

Traditional Chinese medicine composition for treating emphysema Download PDF

Info

Publication number
CN104398884A
CN104398884A CN201410670300.0A CN201410670300A CN104398884A CN 104398884 A CN104398884 A CN 104398884A CN 201410670300 A CN201410670300 A CN 201410670300A CN 104398884 A CN104398884 A CN 104398884A
Authority
CN
China
Prior art keywords
chinese medicine
lung
herba
emphysema
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410670300.0A
Other languages
Chinese (zh)
Inventor
李树旺
刘红梅
吴爱红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410670300.0A priority Critical patent/CN104398884A/en
Publication of CN104398884A publication Critical patent/CN104398884A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/26Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/264Aristolochia (Dutchman's pipe)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating emphysema, which comprises the following traditional Chinese medicine raw materials: 3-5g sambucus chinensis, 4-6g cymbopogon distans, 3-5g tamarix chinensis, 5-8g leaf of Chinese ilex, 3-8g armadillidiam vulgare, 3-5g pleurotus citrinopileatus, 3-5g common fairybells rhizome and root, 5-8g pyrrosia lingua, 5-10g waxgourd seed, 3-6g pink reineckea herb, 3-6g amur lilac seed, 4-5g hispid arthraxon, 3-9g birthwort and 3-9g peganum harmala. The composition employs the pure traditional Chinese medicine raw materials which are compatible to jointly exert effects of removing heat from a lung, dissolving phlegm, calming adverse-rising energy, relieving asthma, strengthening a spleen and tonifying a lung, and the composition has a significant curative effect on the emphysema and has a high effective rate and no toxic or side effects.

Description

One treats emophysematous Chinese medicine composition
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to one and treat emophysematous Chinese medicine composition.
Background technology
Emphysema refer to terminal bronchiole far-end air cavity (respiratory bronchioles, alveolar duct, alveolar sac and alveolar) excessive expansion, or simultaneously with the pathological changes that air cavity wall destroys.Various common emphysema: one, aging-lung emphysema: with age and degenerative change occurs lung tissue gradually, but inorganization destroys, and supply blood vessel does not also reduce, only alveolation and alveolar wall elasticity attenuation, and inner chamber expands, and is called aging-lung emphysema.Two, compensatory emphysema: lung tissue segment loses respiratory function (as the pulmonary collapse is not opened or postoperative at lobectomy of lungs), negative pressure in thoracic cavity is increased, thus have the normal lung tissue of another part excessively to inflate to fill space, be called compensatory emphysema.Three, other intermittent emphysema: pulmonary lobule asks that the alveolar overdistension near fibrous tissue is inflated or fusion of breaking, and forms bulla, is called other intermittent emphysema.Four, bullous emphysema: alveolar ectasia diameter > 1cm person appellation pulmonary belb.The emphysema of pulmonary belb are found when bullous emphysema means that x-ray checks.Five, interstitial emphysema: alveolar or bronchioles wall break, and gas escapes into interstitial lung, is called interstitial emphysema.
Emophysematous pathogenesis is the dificiency of the lung due to protracted disease, susceptible exopathogen, and the turbid storage of expectorant is stayed and caused the state of an illness to increase the weight of differentiation gradually to form, therefore it occurs there is endexoteric two aspect factor with development.1. because the dificiency of the lung due to protracted disease in, lung pattern disease delay mistake as chronic in internal injury chronic cough, asthma, fluid-retention in the chest and hypochondrium, pulmonary tuberculosis etc. is controlled, and does not prolongedly heal, and the turbid heap soil or fertilizer over and around the roots lung of expectorant, gas, also between lung, causes lungs deficient, becomes the basis of morbidity.2. outer because being invaded by exogenous pathogen, insufficiency of lung-QI, weakened defensive QI, exopathogen six climate exopathogens are easily repeatedly taken advantage of a weak point in opponent's defence and are invaded, and bring out this onste.
Emophysematous pathological changes, first at lung, continues, and can affect spleen, kidney, later stage and in the heart.Lung governing qi, department breathe, and open surreptitiously in nose, outside master meter is defended.Therefore exopathogen is often easy in mouth and nose, fur is invaded, attacking the lung first, and pathogenic factor is stopped up stagnant in lung, and air flue is unfavorable, and ascending or descending movement of vital Qi is come in and gone out not normal, sees dyspnea with rapid and short breath, and cough, coughs up phlegm.Another lung is the five internal organs canopy, and lead to him towards hundred arteries and veins dirty, lung being a delicate viscus, not resistance to heresy is invaded, and the pathogenic QI in the body that he is dirty is violated also can make impairment of dispersing and descending function of the lung, lung qi distension, and stop up choke road, it is unfavorable to breathe, and sends out as dyspnea with rapid and short breath.Due to inside and outside combined pathogens, prolongedly not heal, recurrent exerbation, causes lungs deficient eventually.The deficiency of the lung then gas is become homeless master, and lose heart, dyspnea with rapid and short breath increases the weight of day by day.The deficiency of the lung with the passing of time and kidney cause the not main gas of lung, failure of the kidney in receiving QI, dynamic then breathe heavily very, suck difficulty, short breath and difficulty to continue breathing.Due to insufficiency of lung-QI, control joint dereliction of duty, heart can not be assisted a ruler in governing a country and run blood vessels.Heart-yang root is in fire from the gater of life again, suffers from a deficiency of the kidney, the motive, and heart-yang is virtual loss also, blood vessels can not be agitated to run, then the blood stasis of blood is stagnant, and occur that face, lip, tongue, nail matrix are livid purple, dyspnea with rapid and short breath increases the weight of, fullness in the chest must not crouch, and frequently does repeatedly, and lung damage of suffering from a deficiency of the kidney is on the rise formation vicious cycle, and patient's condition is darker.
Summary of the invention
The object of the present invention is to provide and a kind ofly treat the Chinese medicine composition that emphysema are evident in efficacy, effective percentage is high, have no side effect.
The technical solution adopted for the present invention to solve the technical problems is: one treats emophysematous Chinese medicine composition, forms: Herba sambuci chinensis 3-5g, Herba Cymbopogonis 4-6g by the raw material of Chinese medicine of following weight proportioning, Ramulus et Folium Tamaricis 3-5g, Folium Ilicis Purpureae 5-8g, Armadillidium 3-8g, goldentop mushroom 3-5g, Rhizoma dispori flaventis 3-5g, Folium Pyrrosiae 5-8g, Semen Benincasae 5-10g, Herba Reineckeae Carneae 3-6g, Cortex Syringae 3-6g, Herba Arthraxonis Hispidi 4-5g, Fructus Aristolochiae 3-9g, Semen pegani harmalae 3-9g.
Preferably, treat emophysematous Chinese medicine composition, form: Herba sambuci chinensis 4g by the raw material of Chinese medicine of following weight proportioning, Herba Cymbopogonis 4g, Ramulus et Folium Tamaricis 5g, Folium Ilicis Purpureae 5g, Armadillidium 6g, goldentop mushroom 4g, Rhizoma dispori flaventis 4g, Folium Pyrrosiae 6g, Semen Benincasae 8g, Herba Reineckeae Carneae 5g, Cortex Syringae 5g, Herba Arthraxonis Hispidi 4g, Fructus Aristolochiae 8g, Semen pegani harmalae 6g.
The pharmacologically active of each raw material of Chinese medicine of the present invention is as follows:
Herba sambuci chinensis is herb or the root of caprifoliaceae plant Herba sambuci chinensis, sweet acid, temperature, expelling wind and removing dampness, promoting blood circulation to remove blood stasis.Dispelling the wind and dampness pathogens pain, oedema due to nephritis, beriberi edema, dysentery, jaundice, chronic tracheitis, rubella pruritus, erysipelas, skin ulcer swells, traumatic injury, fracture.
Herba Cymbopogonis is the herb of grass Herba Cymbopogonis, pungent, and bitter, warm in nature, induce sweat, dampness removing, relievings asthma, cough-relieving.The summer-heat that cures the wound is caught a cold, and gonorrhea, rheumatism muscles and bones is ached, chronic tracheitis.
Ramulus et Folium Tamaricis is the delicate branch and leaf of Tamaricaceae Ramulus et Folium Tamaricis, tamarix juniperina Bunge or Tamarix ramosissima, and sweet in the mouth is pungent, and property is put down, and returns lung, stomach, heart channel, dispelling wind; Induce sweat; Rash; Removing toxic substances.
Folium Ilicis Purpureae is the blade of holly plant Ilicis Purpureae, bitter, cold, heat-clearing and toxic substances removing, detumescence blood stasis dispelling, for pneumonia, acute because of laryngitis, dysentery, biliary tract infection, urinary tract infection; External treatment burn, ulcer of the lower limb, leprelcosis.Clinical observation is to Folium Ilicis Purpureae to chronic bronchitis, emphysema and bronchiectasic repeated infection, and pulmonary tuberculosis merges acute bronchitis etc. and has good control action.
Armadillidium, for the drying of Armadillidium section animal armadillidum vulgare is all, acid, cool, relieving sore throat and pain, removing blood stasis with potent drugs diuretic.For chronic tracheitis, postoperative pain, toothache, stomatitis, thrush, laryngopharynx swelling and pain, dysuria, amenorrhea.
Goldentop mushroom is the sporophore of Bai Mo section fungus Pleurotus Citrinopileatus Sing, sweet, warm in nature, returns spleen, lung meridian, strengthening by means of tonics; Dysentery relieving.Main weakness is withered disease; Emphysema; Dysentery.
Rhizoma dispori flaventis is rhizome and the root of liliaceous plant cantonese fairy bells, sweet, flat, nourishing the lung to arrest cough, spleen invigorating removing food stagnancy.Control deficient cough with asthma, sputum mixed with blood, discharging fresh blood stool, food stagnation distension." Tian Bao book on Chinese herbal medicine ": " spleen reinforcing, lung moistening, strong muscle.Control discharging fresh blood stool, hemorrhoid.″
Folium Pyrrosiae is Plants of Polypodiaceae Folium Pyrrosiae, the leaf of pyrrosia sheareriChing, pyrrosia drakeanaChing, pyrrosia petiolosaChing, pyrrosiadavidii or pyrrosia gralla Ching, bitter, sweet, cold, returns lung, kidney, urinary bladder channel, relieving stranguria by diuresis; Removing heat from the lung and dissipating phlegm; Cooling blood for hemostasis.Main gonorrhea; Edema; Dysuria; Expectorant heat syndrome cough is breathed heavily; Spitting of blood; Spit blood; Epistaxis; Metrorrhagia; Traumatic hemorrhage.
Semen Benincasae is the seed of cucurbitaceous plant Fructus Benincasae, and sweet in the mouth, cold nature, returns lung, large intestine channel, lung moistening, reduce phlegm, eliminating carbuncle, diuretic.Control phlegm-heat cough, lung abscess, acute appendicitis, gonorrhea, edema, beriberi, hemorrhoid, nasal surface wine Zha.
Herba Reineckeae Carneae is the whole herb with root of liliaceous plant Herba Reineckeae Carneae, sweet, and flat, nourishing the lung to arrest cough, dispels the wind, synthetism.For pulmonary tuberculosis, cough spitting of blood, chronic bronchitis, asthma, rheumatic arthritis; Traumatic injury is controlled in external, fracture.
Cortex Syringae, be the bark of Oleaceae plants syringa reticulata var mandshurica, trunk and stem branch, bitter, pungent, slightly warm in nature, returns lung meridian, and a surname is swollen reduces phlegm; Relieving cough and asthma; Diuretic.Main chronic bronchitis; Asthma; Sudden cardiac edema.
Herba Arthraxonis Hispidi is the herb of grass Herba Arthraxonis Hispidi, bitter, flat, heat clearing away, sending down the abnormal ascending QI, relieving cough and asthma, removing toxic substances, wind-damp dispelling.Cure mainly hepatitis, chronic cough is panted, pharyngolaryngitis, stomatitis, rhinitis, lymphadenitis, mastitis.
Fructus Aristolochiae is the dry mature fruit of aristolochiaceae plant Aristolochia contorta or Fructus Aristolochiae, bitter, and be slightly cold, return lung, large intestine channel, lung heat clearing sending down the abnormal ascending QI, relieving cough and asthma, for dyspnea and cough due to lung-heat, sputum mixed with blood, spitting of blood, aphonia, hemorrhoid complicated by anal fistula swells and ache.Lung heat clearing sending down the abnormal ascending QI, relieving cough and asthma, bowel relieving disappears hemorrhoid." book on Chinese herbal medicine asks former ": " control in lung damp and hot, sound is unclear, and phlegm dyspnea is coughed.Infantile measles is caved in, and dyspnea with fullness of the chest sound is dark, should add and use it.″
Semen pegani harmalae is the seed of zygophyllaceae plant Herba pegani harmalae, and bitter in the mouth is warm in nature, returns lung, Liver Channel, relieving cough and asthma; Wind-damp dispelling; Resolving depression.Main cough and asthma; Dysuria; Joint aches; Numb limbs and tense tendons; Spirit is gloomy; Hysteria.
The present invention has following beneficial effect: the present invention adopts pure raw material of Chinese medicine, and all medicine compatibilities play effect of removing heat from the lung and dissipating phlegm, lowering the adverse QI to relieve asthma, spleen invigorating lung benefiting altogether, and evident in efficacy to emphysema, effective percentage is high, and has no side effect.
Detailed description of the invention
Be below specific embodiments of the invention, technical scheme of the present invention is described further, but protection scope of the present invention is not limited to these embodiments.Every do not deviate from the present invention's design change or equivalent substituting include within protection scope of the present invention.
Embodiment 1
Treat emophysematous Chinese medicine composition, form: Herba sambuci chinensis 3g by the raw material of Chinese medicine of following weight proportioning, Herba Cymbopogonis 5g, Ramulus et Folium Tamaricis 4g, Folium Ilicis Purpureae 8g, Armadillidium 3g, goldentop mushroom 5g, Rhizoma dispori flaventis 3g, Folium Pyrrosiae 7g, Semen Benincasae 10g, Herba Reineckeae Carneae 4g, Cortex Syringae 3g, Herba Arthraxonis Hispidi 5g, Fructus Aristolochiae 5g, Semen pegani harmalae 3g.
Embodiment 2
Treat emophysematous Chinese medicine composition, form: Herba sambuci chinensis 4g by the raw material of Chinese medicine of following weight proportioning, Herba Cymbopogonis 6g, Ramulus et Folium Tamaricis 3g, Folium Ilicis Purpureae 6g, Armadillidium 8g, goldentop mushroom 3g, Rhizoma dispori flaventis 5g, Folium Pyrrosiae 5g, Semen Benincasae 6g, Herba Reineckeae Carneae 3g, Cortex Syringae 4g, Herba Arthraxonis Hispidi 5g, Fructus Aristolochiae 3g, Semen pegani harmalae 9g.
Embodiment 3
Treat emophysematous Chinese medicine composition, form: Herba sambuci chinensis 4g by the raw material of Chinese medicine of following weight proportioning, Herba Cymbopogonis 4g, Ramulus et Folium Tamaricis 5g, Folium Ilicis Purpureae 5g, Armadillidium 6g, goldentop mushroom 4g, Rhizoma dispori flaventis 4g, Folium Pyrrosiae 6g, Semen Benincasae 8g, Herba Reineckeae Carneae 5g, Cortex Syringae 5g, Herba Arthraxonis Hispidi 4g, Fructus Aristolochiae 8g, Semen pegani harmalae 6g.
Embodiment 4
Treat emophysematous Chinese medicine composition, form: Herba sambuci chinensis 5g by the raw material of Chinese medicine of following weight proportioning, Herba Cymbopogonis 4g, Ramulus et Folium Tamaricis 5g, Folium Ilicis Purpureae 7g, Armadillidium 5g, goldentop mushroom 5g, Rhizoma dispori flaventis 4g, Folium Pyrrosiae 8g, Semen Benincasae 5g, Herba Reineckeae Carneae 6g, Cortex Syringae 6g, Herba Arthraxonis Hispidi 4g, Fructus Aristolochiae 9g, Semen pegani harmalae 5g.
Clinical data
Physical data: accept for medical treatment altogether emphysema patient 74 example, wherein male 48 example, women 26 example, age 49-75 year, 60 years old mean age.
Diagnostic criteria: chronic cough, expectoration, pant, dyspnea; Occur the obvious sign of emphysema, barrel chest, respiratory movement weaken; Percussion is hyperresonant note, border of cardiac dullness reduces; X-ray checks abnormal pulmonary function.
Therapeutic Method: Chinese medicine composition of the present invention is decocted in water for oral dose, every day potion, one day twice, sooner or later sub-service one month was a course for the treatment of.
Curative effect judging standard:
Cure: body constitution strengthens, with it energetically; Cough, expectoration, pant, the clinical symptom disappearance such as dyspnea; Emphysema sign disappears.
Effective: body constitution strengthens, with it energetically; Cough, expectoration, pant, the clinical symptom remission such as dyspnea or alleviate.
Invalid: clinical symptoms even increases the weight of without alleviation.
Therapeutic outcome: through the treatment of 1-3 the course for the treatment of, cures 36 examples in 74 routine patients, effective 33 examples, and invalid 5 examples, cure rate 48.6%, total effective rate 93.2%, in therapeutic process, malaise symptoms does not appear in patient.
Model case
Sternly so-and-so, man, 68 years old, suffers from emphysema 2 years, unexpected dyspnea 2 days, recurrent cough, expectoration, breathes heavily 6 years, admission examination barrel chest, and bilateral Breathing movement and vocal fremitus weaken, and are diagnosed as emphysema.By traditional Chinese medicine composition for treating of the present invention after one month, cough, expectoration, asthma shape alleviate, and physical signs of lung is alleviated, and continual cure is physical signs of lung disappearance recovery from illness after two months.

Claims (2)

1. treat an emophysematous Chinese medicine composition, it is characterized in that, be made up of the raw material of Chinese medicine of following weight proportioning: Herba sambuci chinensis 3-5g, Herba Cymbopogonis 4-6g, Ramulus et Folium Tamaricis 3-5g, Folium Ilicis Purpureae 5-8g, Armadillidium 3-8g, goldentop mushroom 3-5g, Rhizoma dispori flaventis 3-5g, Folium Pyrrosiae 5-8g, Semen Benincasae 5-10g, Herba Reineckeae Carneae 3-6g, Cortex Syringae 3-6g, Herba Arthraxonis Hispidi 4-5g, Fructus Aristolochiae 3-9g, Semen pegani harmalae 3-9g.
2. the emophysematous Chinese medicine composition for the treatment of as claimed in claim 1, is characterized in that, form: Herba sambuci chinensis 4g by the raw material of Chinese medicine of following weight proportioning, Herba Cymbopogonis 4g, Ramulus et Folium Tamaricis 5g, Folium Ilicis Purpureae 5g, Armadillidium 6g, goldentop mushroom 4g, Rhizoma dispori flaventis 4g, Folium Pyrrosiae 6g, Semen Benincasae 8g, Herba Reineckeae Carneae 5g, Cortex Syringae 5g, Herba Arthraxonis Hispidi 4g, Fructus Aristolochiae 8g, Semen pegani harmalae 6g.
CN201410670300.0A 2014-11-21 2014-11-21 Traditional Chinese medicine composition for treating emphysema Pending CN104398884A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410670300.0A CN104398884A (en) 2014-11-21 2014-11-21 Traditional Chinese medicine composition for treating emphysema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410670300.0A CN104398884A (en) 2014-11-21 2014-11-21 Traditional Chinese medicine composition for treating emphysema

Publications (1)

Publication Number Publication Date
CN104398884A true CN104398884A (en) 2015-03-11

Family

ID=52636593

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410670300.0A Pending CN104398884A (en) 2014-11-21 2014-11-21 Traditional Chinese medicine composition for treating emphysema

Country Status (1)

Country Link
CN (1) CN104398884A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101249228A (en) * 2008-04-11 2008-08-27 李英格 Mongolian medicine for curing lung interstitial substance fibrosis
CN102319385A (en) * 2011-09-08 2012-01-18 闫振国 Medicament for treating emphysema and preparation method thereof
CN102451254A (en) * 2010-10-22 2012-05-16 黄才华 Medicine for treating emphysema
CN103705742A (en) * 2013-12-22 2014-04-09 栗振 Traditional Chinese medicine composite for treating lung-kidney qi deficiency type emphysema

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101249228A (en) * 2008-04-11 2008-08-27 李英格 Mongolian medicine for curing lung interstitial substance fibrosis
CN102451254A (en) * 2010-10-22 2012-05-16 黄才华 Medicine for treating emphysema
CN102319385A (en) * 2011-09-08 2012-01-18 闫振国 Medicament for treating emphysema and preparation method thereof
CN103705742A (en) * 2013-12-22 2014-04-09 栗振 Traditional Chinese medicine composite for treating lung-kidney qi deficiency type emphysema

Similar Documents

Publication Publication Date Title
CN103110730B (en) Perillaseed-radix scutellariae-almond decoction for treating asthma and preparation method thereof
CN103028093B (en) Traditional Chinese medicine composition for treating chronic obstructive pulmonary emphysema and preparation method of traditional Chinese medicine composition
CN104436102A (en) Traditional Chinese medicine for treating asthma
CN104398884A (en) Traditional Chinese medicine composition for treating emphysema
CN104474256A (en) Oral liquor for treating acquired immunodeficiency syndrome lung infection
CN102743708B (en) Cordyceps sinensis and gecko powder for treating emphysema pulmonary heart disease asthma chronic bronchitis
CN109793852A (en) A kind of cough-relieving, resolving sputum and the Chinese medicine composition relievingd asthma
CN104771733B (en) A kind of Chinese medicine composition for treating chronic bronchitis
CN107714918A (en) A kind of clearing lung and eliminating phlegm and relieving cough and asthma capsule medicine and preparation method
CN107335021A (en) A kind of pill medicine and preparation method for treating icteric hepatitis
CN107469021A (en) It is a kind of to be used to treat pill medicine of chest impediment and cardialgia and preparation method thereof
CN107375686A (en) A kind of Chinese medicine composition and preparation method that can effectively treat vital myocarditis
CN106822779A (en) A kind of Chinese medicine composition of the obstruction of qi in the chest and palpitation and insomnia for treating caused by energy stagnation and blood stasis
CN106215055A (en) A kind of capsule medicine treating Pulmonary Fungal Infections and preparation method thereof
CN105853749A (en) Pharmaceutical preparation for treating chronic pneumonia and preparing method
CN104983840A (en) Chinese medicine composition for treating rhinitis
CN104474210A (en) Traditional Chinese medicine composition for treating unstable angina pectoris caused by qi stagnation and blood stasis
CN103977381A (en) Drug for treating carbon monoxide poisoning sequelae
CN103212005A (en) Traditional Chinese medicine composition for treatment of wind-dryness cough
CN108030843A (en) A kind of Chinese medicine for treating pulmonary emphysema
CN107115499A (en) It is a kind of to be used to treat new medicine composition of pneumoconiosis and preparation method thereof
CN107468970A (en) A kind of pill medicine for treating infantile cough and preparation method thereof
CN108837090A (en) A kind of Chinese medicine composition and preparation method for Intensive Care Therapy infection in respiratory system
CN107349404A (en) It is a kind of to be used to treat endo-medicine of pneumonia and pulmonary emphysema and preparation method thereof
CN107823584A (en) It is a kind of to treat noisy pill medicine and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150311

RJ01 Rejection of invention patent application after publication